Holen Sie sich die Stockscreener-App
49.33
0.88%
0.43
Handel nachbörslich:
49.40
0.07
+0.14%
Schlusskurs vom Vortag:
$48.90
Offen:
$48.99
24-Stunden-Volumen:
689.74K
Relative Volume:
1.50
Marktkapitalisierung:
$1.56B
Einnahmen:
$566.77M
Nettoeinkommen (Verlust:
$48.16M
KGV:
41.45
EPS:
1.19
Netto-Cashflow:
$274.29M
1W Leistung:
+2.01%
1M Leistung:
+8.80%
6M Leistung:
+66.66%
1J Leistung:
+64.32%
1-Tages-Spanne:
$48.87
$49.92
1-Wochen-Bereich:
$47.83
$49.92
52-Wochen-Spanne:
$23.23
$49.92
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Firmenname
Collegium Pharmaceutical Inc
Sektor
Telefon
781-713-3699
Adresse
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Vergleichen Sie COLL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
49.33 | 1.55B | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
122.76 | 53.87B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.83 | 45.71B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.73B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.32 | 34.49B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
507.00 | 22.00B | 3.08B | 1.24B | 1.07B | 25.61 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-01-10 | Hochstufung | Needham | Hold → Buy |
| 2024-07-30 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | Hochstufung | Jefferies | Hold → Buy |
| 2024-05-10 | Herabstufung | Needham | Buy → Hold |
| 2024-05-10 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2023-08-25 | Bestätigt | Needham | Buy |
| 2023-05-02 | Fortgesetzt | Jefferies | Buy |
| 2022-08-08 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-14 | Eingeleitet | BWS Financial | Sell |
| 2020-05-27 | Eingeleitet | Guggenheim | Neutral |
| 2020-02-19 | Fortgesetzt | Jefferies | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-05-03 | Fortgesetzt | H.C. Wainwright | Buy |
| 2019-04-12 | Fortgesetzt | Janney | Buy |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2019-01-16 | Bestätigt | Needham | Buy |
| 2018-03-08 | Bestätigt | H.C. Wainwright | Buy |
| 2018-02-07 | Bestätigt | Needham | Buy |
| 2017-12-05 | Bestätigt | Needham | Buy |
| 2017-09-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-05-11 | Bestätigt | Needham | Buy |
| 2016-09-13 | Eingeleitet | Gabelli & Co | Buy |
| 2015-06-01 | Eingeleitet | Jefferies | Buy |
| 2015-06-01 | Eingeleitet | Needham | Buy |
| 2015-06-01 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten
Strong Q3 Beat and Guidance Upside Might Change The Case For Investing In Collegium Pharmaceutical (COLL) - simplywall.st
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment? - 富途牛牛
Collegium Pharma spikes after 2025 outlook - MSN
Collegium Pharmaceutical (COLL): Valuation Check After Strong Revenue Beat and Upgraded Full-Year Performance - simplywall.st
Collegium Pharmaceutical (NASDAQ:COLL) Sets New 1-Year HighShould You Buy? - MarketBeat
Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL) - Yahoo Finance
Needham Upgrades Collegium Pharmaceutical (COLL) - MSN
Collegium Pharmaceutical Inc 354 Stock Analysis and ForecastMarket Volatility Update & Exceptional Return Growth - earlytimes.in
Insider Selling: Collegium Pharmaceutical (NASDAQ:COLL) EVP Sells 17,600 Shares of Stock - MarketBeat
Collegium Pharmaceutical stock hits all-time high at 49.11 USD By Investing.com - Investing.com Canada
Collegium Pharmaceutical stock hits all-time high at 49.11 USD - Investing.com
Collegium pharmaceutical EVP Dreyer sells $847k in stock By Investing.com - Investing.com India
Collegium pharmaceutical EVP Dreyer sells $847k in stock - Investing.com
Collegium Pharmaceutical Insider Sold Shares Worth $847,855, According to a Recent SEC Filing - marketscreener.com
Collegium Pharmaceutical (NASDAQ:COLL) Now Covered by Analysts at Barclays - MarketBeat
Does Zacks’ Value Spotlight on Collegium (COLL) Reframe Its Cash-Flow Story for Investors? - simplywall.st
Collegium Pharmaceutical (NASDAQ:COLL) Director Rita Balice-Gordon Sells 3,650 Shares - MarketBeat
Barclays Initiates Collegium Pharmaceutical at Overweight With $58 Price Target - marketscreener.com
Collegium Pharmaceutical (NASDAQ:COLL) Hits New 12-Month HighWhat's Next? - MarketBeat
Collegium Pharmaceutical (COLL): Revisiting Valuation After Fresh Coverage and Ongoing Earnings Outperformance - Yahoo Finance
Collegium Pharmaceutical (COLL): Assessing Valuation After Earnings Beats, Strong Zacks Rating and Value Investor Interest - simplywall.st
Can Collegium Pharmaceutical Inc. stock withstand economic slowdown2025 Sector Review & Safe Investment Capital Preservation Plans - Newser
Collegium Pharmaceutical, Inc. (COLL) Hits Fresh High: Is There Still Room to Run? - sharewise.com
Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now? - sharewise.com
Can Collegium Pharmaceutical Inc. (354) stock hit consensus price targetsJuly 2025 News Drivers & Consistent Growth Stock Picks - Newser
What RSI levels show for Collegium Pharmaceutical Inc. (354) stockEarnings Trend Report & Weekly High Return Forecasts - Newser
How Collegium Pharmaceutical Inc. stock responds to policy changesWeekly Trade Recap & Real-Time Stock Movement Alerts - Newser
Collegium Pharmaceutical (NASDAQ:COLL) Sets New 12-Month HighStill a Buy? - MarketBeat
Will Collegium Pharmaceutical Inc. (354) stock justify high valuationQuarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - Newser
Will Collegium Pharmaceutical Inc. (354) stock benefit from commodity supercycle2025 Investor Takeaways & Weekly Chart Analysis and Guides - Newser
Will Collegium Pharmaceutical Inc. (354) stock sustain uptrend momentum2025 Momentum Check & Free Expert Verified Stock Movement Alerts - Newser
Collegium Pharmaceutical stock hits all-time high at 48.19 USD By Investing.com - Investing.com Australia
Collegium Pharmaceutical stock hits all-time high at 48.19 USD - Investing.com
Loomis Sayles & Co. L P Increases Position in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Will Collegium Pharmaceutical Inc. (354) stock hit analyst forecastsWeekly Stock Report & AI Enhanced Trade Execution Alerts - Newser
Can Collegium Pharmaceutical Inc. (354) stock withstand sector downturnsPortfolio Risk Report & AI Driven Price Forecasts - Newser
Why Collegium Pharmaceutical Inc. (354) stock is a strong analyst pickTrade Volume Report & Real-Time Volume Surge Alerts - Newser
Ballast Asset Management LP Makes New Investment in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Geode Capital Management LLC Increases Stock Holdings in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Collegium Pharmaceutical, Inc. (COLL) Stock Forecasts - Yahoo Finance
Finanzdaten der Collegium Pharmaceutical Inc-Aktie (COLL)
Umsatz
Nettogewinn
Free Cashflow
ENV
12.55%
0.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):